|
||||||
Executive Summary Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company VolitionRX Ltd - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 VolitionRX Ltd Company Overview 6 VolitionRX Ltd Company Snapshot 6 VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6 VolitionRX Ltd-Pipeline Analysis Overview 8 VolitionRX Ltd-Key Facts 8 VolitionRX Ltd-Major Products and Services 9 VolitionRX Ltd Pipeline Products by Development Stage 10 VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14 VolitionRX Ltd Pipeline Products Overview 16 HyperGenomics Diagnostic Test-Colon Cancer 16 HyperGenomics Diagnostic Test-Colon Cancer Product Overview 16 HyperGenomics Diagnostic Test-Leukaemia 17 HyperGenomics Diagnostic Test-Leukaemia Product Overview 17 HyperGenomics Diagnostic Test-Prostate Cancer 18 HyperGenomics Diagnostic Test-Prostate Cancer Product Overview 18 Nu.Q CRC Screening Test 19 Nu.Q CRC Screening Test Product Overview 19 Nu.Q CRC Screening Test Clinical Trial 20 Nu.Q CRC Symptomatic Test 21 Nu.Q CRC Symptomatic Test Product Overview 21 Nu.Q CRC Triage Test 22 Nu.Q CRC Triage Test Product Overview 22 Nu.Q Frontline Asymptomatic CRC Screening Test 23 Nu.Q Frontline Asymptomatic CRC Screening Test Product Overview 23 Nu.Q Frontline Asymptomatic CRC Screening Test Clinical Trial 24 NuQ-A Androgen Receptor Cell Culture ELISA Kit 25 NuQ-A Androgen Receptor Cell Culture ELISA Kit Product Overview 25 NuQ-A EZH2 Cell Culture ELISA Kit 26 NuQ-A EZH2 Cell Culture ELISA Kit Product Overview 26 NuQ-A HMGB1 Cell Culture ELISA Kit 27 NuQ-A HMGB1 Cell Culture ELISA Kit Product Overview 27 NuQ-A Oestrogen Receptor Cell Culture ELISA Kit 28 NuQ-A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 28 NuQ-A Progesterone Receptor Cell Culture ELISA Kit 29 NuQ-A Progesterone Receptor Cell Culture ELISA Kit Product Overview 29 NuQ-Prostate Cancer 30 NuQ-Prostate Cancer Product Overview 30 NuQ-Prostate Cancer Clinical Trial 31 NuQ-T001 Total Nucleosome ELISA Kit 32 NuQ-T001 Total Nucleosome ELISA Kit Product Overview 32 NuQ Diagnostic Test-Lung Cancer 33 NuQ Diagnostic Test-Lung Cancer Product Overview 33 NuQ Diagnostic Test-Lung Cancer Clinical Trial 34 NuQ Diagnostic Test-Pancreatic Cancer 35 NuQ Diagnostic Test-Pancreatic Cancer Product Overview 35 NuQ Diagnostic Test-Pancreatic Cancer Clinical Trial 36 NuQ Endo 37 NuQ Endo Product Overview 37 NuQ Endo Clinical Trial 38 NuQ T003 Assay-Colorectal Cancer 39 NuQ T003 Assay-Colorectal Cancer Product Overview 39 NuQ V001 Assay-Colorectal Cancer 40 NuQ V001 Assay-Colorectal Cancer Product Overview 40 NuQ X001S Assay-Colorectal Cancer 41 NuQ X001S Assay-Colorectal Cancer Product Overview 41 NuQ X001S Assay-Colorectal Cancer Clinical Trial 42 NuQ-B 43 NuQ-B Product Overview 43 NuQ-IHC 44 NuQ-IHC Product Overview 44 NuQ-M Gamma-H2AX Cell Culture ELISA Kit 45 NuQ-M Gamma-H2AX Cell Culture ELISA Kit Product Overview 45 NuQ-M H3K27(Me)3 Cell Culture ELISA Kit 46 NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview 46 NuQ-M H4K16(Ac) Cell Culture ELISA Kit 47 NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview 47 NuQ-M H4K20(Me)3 Cell Culture ELISA Kit 48 NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview 48 NuQ-M H4Pan(Ac) Cell Culture ELISA Kit 49 NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview 49 NuQ-M Ubiquityl H2A Cell Culture ELISA Kit 50 NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview 50 NuQ-V 51 NuQ-V Product Overview 51 NuQ-V mH2A1.1 Cell Culture ELISA Kit 52 NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview 52 NuQ-V mH2A2 Cell Culture ELISA Kit 53 NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview 53 NuQ-X Hydroxymethylated DNA Cell Culture Kit 54 NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview 54 NuQ-X Methylated DNA Cell Culture Kit 55 NuQ-X Methylated DNA Cell Culture Kit Product Overview 55 VolitionRX Ltd-Key Competitors 56 VolitionRX Ltd-Key Employees 57 VolitionRX Ltd-Locations And Subsidiaries 58 Head Office 58 Other Locations & Subsidiaries 58 Recent Developments 59 VolitionRX Ltd, Recent Developments 59 Jul 10, 2018: Volition expands clinical development of Nu.Q to Asia Pacific 59 May 10, 2018: VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 59 May 09, 2018: VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 60 Mar 07, 2018: VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 60 Mar 01, 2018: VolitionRX Announces Full Fiscal Year 2017 Financial Results and Business Update 61 Feb 26, 2018: VolitionRx Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer 62 Feb 05, 2018: VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark 63 Jan 03, 2018: VolitionRx Releases Letter to Shareholders Including Status Update on Key Clinical Milestone 63 Nov 09, 2017: VolitionRx Announces Third Quarter 2017 Financial Results and Business Update 64 Sep 22, 2017: VolitionRx Announces the Initial Sale of its New Nu.Q Research Kits 65 Appendix 66 Methodology 66 About GlobalData 69 Contact Us 69 Disclaimer 69 List of Figures VolitionRX Ltd Pipeline Products by Equipment Type 7 VolitionRX Ltd Pipeline Products by Development Stage 10 VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14 List of Tables VolitionRX Ltd Pipeline Products and Ongoing Clinical Trials Overview 6 VolitionRX Ltd Pipeline Products by Equipment Type 7 VolitionRX Ltd Pipeline Products by Indication 7 VolitionRX Ltd Ongoing Clinical Trials by Trial Status 7 VolitionRX Ltd, Key Facts 8 VolitionRX Ltd, Major Products and Services 9 VolitionRX Ltd Number of Pipeline Products by Development Stage 10 VolitionRX Ltd Pipeline Products Summary by Development Stage 11 VolitionRX Ltd Ongoing Clinical Trials by Trial Status 14 VolitionRX Ltd Ongoing Clinical Trials Summary 15 HyperGenomics Diagnostic Test-Colon Cancer-Product Status 16 HyperGenomics Diagnostic Test-Colon Cancer-Product Description 16 HyperGenomics Diagnostic Test-Leukaemia-Product Status 17 HyperGenomics Diagnostic Test-Leukaemia-Product Description 17 HyperGenomics Diagnostic Test-Prostate Cancer-Product Status 18 HyperGenomics Diagnostic Test-Prostate Cancer-Product Description 18 Nu.Q CRC Screening Test-Product Status 19 Nu.Q CRC Screening Test-Product Description 19 Nu.Q CRC Screening Test-A Large Multi-center US Clinical Study of Nu.Q Assay in the Screening of Colorectal Cancer 20 Nu.Q CRC Screening Test-Prospective Clinical Study Nu.Q Assay for the Detection of Colorectal Cancer 20 Nu.Q CRC Symptomatic Test-Product Status 21 Nu.Q CRC Symptomatic Test-Product Description 21 Nu.Q CRC Triage Test-Product Status 22 Nu.Q CRC Triage Test-Product Description 22 Nu.Q Frontline Asymptomatic CRC Screening Test-Product Status 23 Nu.Q Frontline Asymptomatic CRC Screening Test-Product Description 23 Nu.Q Frontline Asymptomatic CRC Screening Test-Asymptomatic Colorectal Cancer (CRC) Frontline Screening Study 24 NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Status 25 NuQ-A Androgen Receptor Cell Culture ELISA Kit-Product Description 25 NuQ-A EZH2 Cell Culture ELISA Kit-Product Status 26 NuQ-A EZH2 Cell Culture ELISA Kit-Product Description 26 NuQ-A HMGB1 Cell Culture ELISA Kit-Product Status 27 NuQ-A HMGB1 Cell Culture ELISA Kit-Product Description 27 NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Status 28 NuQ-A Oestrogen Receptor Cell Culture ELISA Kit-Product Description 28 NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Status 29 NuQ-A Progesterone Receptor Cell Culture ELISA Kit-Product Description 29 NuQ-Prostate Cancer-Product Status 30 NuQ-Prostate Cancer-Product Description 30 NuQ-Prostate Cancer-A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer 31 NuQ-Prostate Cancer-Evaluate the Accuracy of Nu.Q Assay in Diagnosis of Aggressive Prostate Cancer 31 NuQ-Prostate Cancer-Multicenter study to evaluate ability of NuQ to detect prostate cancer 31 NuQ-T001 Total Nucleosome ELISA Kit-Product Status 32 NuQ-T001 Total Nucleosome ELISA Kit-Product Description 32 NuQ Diagnostic Test-Lung Cancer-Product Status 33 NuQ Diagnostic Test-Lung Cancer-Product Description 33 NuQ Diagnostic Test-Lung Cancer-Detection of Lung Cancer with NuQ Blood Test 34 NuQ Diagnostic Test-Lung Cancer-Study to evaluate NuQ for early detection of 27 most prevalent cancers; and to evaluate differences in nucleosome structures between cancers 34 NuQ Diagnostic Test-Pancreatic Cancer-Product Status 35 NuQ Diagnostic Test-Pancreatic Cancer-Product Description 35 NuQ Diagnostic Test-Pancreatic Cancer-Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 36 NuQ Endo-Product Status 37 NuQ Endo-Product Description 37 NuQ Endo-Study to Evaluate the Efficacy of Nu.Q Platform Technology in Diagnosis of Endometriosis 38 NuQ T003 Assay-Colorectal Cancer-Product Status 39 NuQ T003 Assay-Colorectal Cancer-Product Description 39 NuQ V001 Assay-Colorectal Cancer-Product Status 40 NuQ V001 Assay-Colorectal Cancer-Product Description 40 NuQ X001S Assay-Colorectal Cancer-Product Status 41 NuQ X001S Assay-Colorectal Cancer-Product Description 41 NuQ X001S Assay-Colorectal Cancer-Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study 42 NuQ-B-Product Status 43 NuQ-B-Product Description 43 NuQ-IHC-Product Status 44 NuQ-IHC-Product Description 44 NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Status 45 NuQ-M Gamma-H2AX Cell Culture ELISA Kit-Product Description 45 NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Status 46 NuQ-M H3K27(Me)3 Cell Culture ELISA Kit-Product Description 46 NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Status 47 NuQ-M H4K16(Ac) Cell Culture ELISA Kit-Product Description 47 NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Status 48 NuQ-M H4K20(Me)3 Cell Culture ELISA Kit-Product Description 48 NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Status 49 NuQ-M H4Pan(Ac) Cell Culture ELISA Kit-Product Description 49 NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Status 50 NuQ-M Ubiquityl H2A Cell Culture ELISA Kit-Product Description 50 NuQ-V-Product Status 51 NuQ-V-Product Description 51 NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Status 52 NuQ-V mH2A1.1 Cell Culture ELISA Kit-Product Description 52 NuQ-V mH2A2 Cell Culture ELISA Kit-Product Status 53 NuQ-V mH2A2 Cell Culture ELISA Kit-Product Description 53 NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Status 54 NuQ-X Hydroxymethylated DNA Cell Culture Kit-Product Description 54 NuQ-X Methylated DNA Cell Culture Kit-Product Status 55 NuQ-X Methylated DNA Cell Culture Kit-Product Description 55 VolitionRX Ltd, Key Employees 57 VolitionRX Ltd, Subsidiaries 58 Glossary 68 Single User License: Site License: Corporate User License: SciGen Ltd PathGEN Dx Pte. Ltd. Kino Biotech Co Ltd Epigenomics AG Abbott Laboratories Ab Sciex Pte Ltd VolitionRX Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |